Facebook Twitter Instagram
    RECENT:
    • EDD 2022 – Spain
    • EDD 2022 – Russia
    • EDD 2022 – Portugal
    • EDD 2022 – Germany
    • EDD 2022 – France
    • EDD 2022 – Croatia
    • EDD 2022 – Belgium
    • EDD 2022 – Flyer
    • EDD 2021 – Italia
    • EDD 2021 – Belgium
    Facebook Twitter Instagram
    Tuesday, February 7
    European Depression Association
    Facebook Twitter Instagram
    • Home
    • About us
    • Board
    • Manifesto
    • EDD 2022
    • Previous editions
    • Articles
    • Links
    • Contact US
    European Depression Association
    Home»Articles»Psychiatria Danubina – International Twined Congress – Psychiatry beyond DSM-5

    Psychiatria Danubina – International Twined Congress – Psychiatry beyond DSM-5

    0
    By Webmaster on 13 May 2019 Articles
    Share
    Facebook Twitter LinkedIn WhatsApp
    Psychiatria Danubina, 2018; Vol. 30, Suppl. 7
    Click to download

    EDITORIALS

    It is my pleasure to indroduce you, as president of Psychiatric Studies Centre and chair of the congress, to the fifth edition of this international congress held in Iseo, a very attractive town on the lake of Iseo, in Italy. This time, as four years ago, the scientific management of the meeting has been done not only by Psychiatric Studies Centre but together with the Université Catholique de Louvain (Belgium), the Centre Hospitalier Universitaire et Psychiatrique de Mons Borinage (Brussels, Belgium), and the Bedfordshire Centre for Mental Health Research in association with the University of Cambridge (BCMHR-UC, UK).

    As in past congress edition in Iseo, we have obtained the co-sponsorship of the World Psychiatric Association (Evidence Based Psychiatry WPA Section) and of the Italian Health Office.

    This twined congress follows the others, which have been held in Brussels and in Cambridge every two years since 2010, with the plan of continuing to hold them every two years also in future.

    The programme includes 56 papers (regular presentations, short presentations and posters), in less then 3 days, so as to intensely stimulate all the delegates on several topics of psychiatry, ranging from research to clinical practice , in order to illustrate the broad spectrum of science within the field of psychiatry.

    Many thanks to all speakers and authors; but a particular thanks goes to the Centre Hospitalier Universitaire et Psychiatrique de Mons Borinage of Brussels for its support in printing these scientific papers.

    Giuseppe Tavormina, MD
    President of “Psychiatric Studies Centre” (Cen.Stu.Psi.)
    Provaglio d’Iseo (BS), Italy

    An international congress is an opportunity to exchange ideas and progress together.

    It’s an opportunity to interact with other members of the scientific community, to meet colleagues, to meet people who are known by their writings and other delegates from the same country and from other countries, to share ideas, to create professional links.

    It is an opportunity to transmit what we do and also to learn what is done elsewhere, to acquire knowledge sharing points of view from research and practices,

    It is a way to take collective positions, to confront the orientations during the debates, to discover new perspectives, to measure the stakes, to apprehend the tendencies and orientations of the public health policies and management resources for health professionals, to act as a member of a community, to make proposals supported by a community.

    These are issues to promote innovation, exercise leadership and influence public health policies.

    Thank you to all who have made this event possible in the past years until today. Thanks to all the participants, authors and speakers, thanks to Psychiatrica Danubina. Thanks to Mark Agius and Nicolas Zdanowicz for their incredible contribution over the years. Special thanks for the one who took the leadership to make us grow and progress together this year: Dr. Giuseppe Tavormina.

    Juan Martin Tecco, MD, MBA
    Centre Hospitalier Universitaire et Psychiatrique de Mons-Borinage (CHUP-MB)
    Mons, Belgium

    For several years, biological model is running out of innovative molecules. We managed to limit undesirable effects but the efficacy of our molecules reaches its limit. It is the case for antidepressants as well as for neuroleptic drugs. However, this brake on biological research didn’t shake the dynamism of our congress. Even if there are less communications about psychopharmacology, the other branches of psychiatry show an updated dynamism: social psychiatry, art therapy, care organization policy, psychotherapy, consequences of stress and recovery after stress, personality troubles… Concerning psychopharmacology, the researches performed aim to use interactions between different fields such as immune system and psychobiology, therapeutic collaboration and antidepressants, physical and mental health, care and ethics. Our congress has still a bright future.

    Prof. Nicolas Zdanowicz, MD, PhD
    Université Catholique de Louvain, Psychosomatics Unit,
    Mont-Godinne University Hospital
    Yvoir, Belgium
    Share. Facebook Twitter LinkedIn WhatsApp

    Related Articles

    “G.T. Mixed States Rating Scales”, or “G.T. MSRS”

    22 May 2019

    Early Intervention in Bipolar Disorder

    13 May 2019

    Depression and suicide on Gotland: an intensive study of all suicides before and after a depression-training programme for general practitioners

    13 May 2019

    Comments are closed.

    THE HANDBOOK ON DEPRESSION AND MOOD DISORDER

    Croatian versionFrench versionItalian versionLatvian versionPortuguese versionRussian versionSpanish versionTurkey version

    Facebook Twitter Instagram LinkedIn
    • Home
    • About us
    • Contact us
    • Cookie Policy (EU)
    © 2023 European Depression Association. Designed by AR Engineering.

    Type above and press Enter to search. Press Esc to cancel.

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}